100 related articles for article (PubMed ID: 6172102)
1. Head and neck cancer. Relationship of the prechemotherapy serum alkaline phosphatase levels to response rate of induction chemotherapy.
Coker DD; Morris D; Elias EG; Didolkar MS; Zentai TA
Arch Otolaryngol; 1982 Jan; 108(1):28-9. PubMed ID: 6172102
[TBL] [Abstract][Full Text] [Related]
2. Significance of alkaline phosphatase and chemotherapy for head and neck carcinoma.
Burres SA; Jacobs JR; Peppard SB; Al-Sarraf M
Otolaryngol Head Neck Surg; 1982; 90(2):188-92. PubMed ID: 6180367
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators in chemotherapy for head and neck carcinoma: alkaline phosphatase levels.
Katz AE; Hong WK; Bhutani R; Berman LD; Blanchard GJ; Koff RS; Shapshay SM; Strong MS
Laryngoscope; 1980 Jun; 90(6 Pt 1):924-9. PubMed ID: 7382708
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Schröder M; von Heyden HW; Beyer JH; Klee M
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
[No Abstract] [Full Text] [Related]
7. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
Davis S; Kessler W
Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
[No Abstract] [Full Text] [Related]
8. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
[No Abstract] [Full Text] [Related]
9. [Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck].
Bruntsch U; Hiller T; Wandt H; Wolff L; Theissing J; Gallmeier WM
Dtsch Med Wochenschr; 1985 Dec; 110(49):1889-92. PubMed ID: 2415315
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of squamous cell carcinoma of the head and neck.
Greenberg BR
Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
[No Abstract] [Full Text] [Related]
11. Future directions in the chemotherapy of head and neck cancer.
Grunberg SM
Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
[TBL] [Abstract][Full Text] [Related]
13. [Pathohistologic changes after induction cytostatic therapy with methotrexate (M), bleomycin (B) and cisplatin (P)--(MBP)].
Böheim K; Mikuz G; Böheim C
Laryngol Rhinol Otol (Stuttg); 1982 May; 61(5):246-50. PubMed ID: 6178922
[TBL] [Abstract][Full Text] [Related]
14. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
Jahnke V
HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in head and neck cancer.
Hong WK; Bromer R
N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588
[No Abstract] [Full Text] [Related]
17. Preoperative cisplatin and bleomycin therapy in head and neck squamous carcinoma. Prognostic factors for tumor response.
Baker SR; Makuch RW; Wolf GT
Arch Otolaryngol; 1981 Nov; 107(11):683-9. PubMed ID: 6170283
[TBL] [Abstract][Full Text] [Related]
18. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
20. Single agents known to be active in head and neck cancer.
Monfardini S; Volonterio A; Marchini S
Chemioterapia; 1985 Aug; 4(4):303-9. PubMed ID: 2414016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
